Grow your microbiome services with MASSBIOME.
From white-label microbiome products to laboratory reporting, API integration, distribution and research collaborations — let's find the partnership model that fits your business, together.
One platform. Multiple ways to partner.
Whether you want to launch your own branded test, integrate MASSBIOME into your digital ecosystem, add microbiome reporting to your laboratory, distribute the solution in your territory, support your patients or run a research project, we'll shape the collaboration around your needs.
White-Label Partner — Own Brand
Launch a microbiome analysis product under your own brand, powered by MASSBIOME technology, analysis and reporting infrastructure.
White-Label Partner — API Integration
Offer microbiome analysis inside your own application, portal or healthcare ecosystem through API-based integration with MASSBIOME.
Laboratory Partner
Run gut microbiome analysis in-house. Sequence with Oxford Nanopore technology and get automated analysis and structured reports for your laboratory or your clients.
Distributor / Reseller
Bring MASSBIOME into your market through your established laboratory, healthcare or life-science distribution network.
Healthcare Professional
Offer gut microbiome analysis to your patients through your clinic, practice or nutrition service, without setting up a laboratory workflow yourself.
Research
You are planning a microbiome study and need sequencing, taxonomic analysis, functional evaluation or scientific expertise for your research project.
A partnership built around more than software.
MASSBIOME brings together long-read microbiome sequencing, automated bioinformatics, structured reporting, laboratory workflow know-how and dedicated support from Massive Bioinformatics — in one B2B platform.
Which partnership model fits your business?
Tell us how you'd like to work with microbiome analysis, and our team will help you define the most suitable technical and commercial model.
Disclaimer
MASSBIOME is a Clinical Decision Support Software (CDSS)
providing microbiome composition analysis for clinical decision support.
Results are intended for use by qualified healthcare professionals
as part of their overall patient assessment.
MASSBIOME does not provide medical diagnoses or treatment recommendations
and is not intended to diagnose, treat, cure or prevent any disease.
MASSBIOME is a trademark of Massive Bioinformatics ARGE Teknolojileri A.Ş.
